ALLISON BALLMER

International Business Leader, Global Marketing Strategy, Roche Sequencing

Allison Ballmer is International Business Leader at Roche Sequencing, leading the Global Marketing Strategy and Lifecycle Plan for Roche’s Next Generation technology.  Prior to joining Roche, Ballmer lead the Global Marketing and Commercialization for Swiss-based Molecular Diagnostics arm of Biocartis. She held various Business Development and Commercial leadership roles in Molecular Diagnostics with a particular emphasis in Oncology, launching Ventana’sCompanion Diagnostic for Herceptin therapy and enabling companion LDTs. She began her career in Cancer Diagnostics holdingleadership roles in Quality, Regulatory and Operations Management. Ms Ballmer earned her B.S. in Mechanical Engineering from Virginia Tech andMarketing certifications from Cornell University.

 

Session: NGS AND Clinical Interplay

The adoption of Personalized Medicine is in part being driven by the omnipresence of Next-Generation Sequencing (NGS) and the fast-paced technological innovations. As a result, we can see the clinical sector responding with voicing their needs, and the industry adapting to deliver solutions that change clinical medicine and healthcare into patient-centered. This panel will focus on clinical requirements, new advancements, and the different challenges they encounter to advance genomics into the clinic.

Web Analytics